CLINICAL_TRIALS
trial_result
· 2013-08-09
Clinical Trial Update: Phase 3 Study of Pelubiprofen Tab. & Celebrex Cap. in Rheumatoid Arthritis Patients [Phase 3]
Summary
A Phase 3 study comparing pelubiprofen tablets with Celebrex capsules in rheumatoid arthritis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daewon Pharmaceutical Co., Ltd. | Conditions: Pelubiprofen, Celebrex | Phase 3 | Status: COMPLETED